Stem Cell Transplantation Remains Standard of Care in Multiple MyelomaCuretoday.comStem Cell Transplantation Remains Standard of Care in Multiple Myeloma. Patients with multiple myeloma who are eligible for stem cell transplantation should still be con… Continue reading
Synthetic Biology Worldwide Market Outlook to 2023: Emerging …Facts of WeekSynthetic Biology Market analysis is provided for global market including development trends by regions, competitive analysis of Synthetic Biology market. This report describe… Continue reading
Asbestos.comMesothelioma Immunotherapy Trial Involves Targeted RadiationAsbestos.comMemorial Sloan Kettering Cancer Center in New York City has opened a clinical trial for mesothelioma involving a combination of targeted radiation and the novel immunot… Continue reading
WOWTNew Therapy Offers Another Chance for Patients with Blood CancersWOWTThe relapse rate for first time treatment of non-Hodgkin lymphoma is 30 percent and 40 percent for acute lymphoblastic leukemia. The majority of these patients will then go on to … Continue reading
Racial disparities persist in stem cell transplant for multiple myelomaHealioATLANTA — More non-Hispanic whites underwent hematopoietic stem cell transplant for initial therapy for multiple myeloma compared with non-Hispanic blacks, non-Hispanic Asians… Continue reading
Drug Target ReviewDoctors Said Immunotherapy Would Not Cure Her Cancer. They Were Wrong.New York TimesThe women, strangers to one another living in different countries, asked their doctors to try new immunotherapy drugs that had revolutionized treatmen… Continue reading
Brinkwire (press release) |
CRISPR scissors, Cas12a, enable cutting-edge diagnostics.
Brinkwire (press release) She said: ‘We continue to be fascinated by the functions of bacterial CRISPR systems and how mechanistic understanding leads to opportunities for new technologies.’ ‘CRISPR-Cas12a, [a]DNA-cutting protein, has an unexpected side effect that makes it an … |
|
CRISPR pioneer’s lab develops system to target infections and cancer
BioNews Researchers have developed a new application for CRISPR, adapting the system to detect viral infections with high accuracy, a new study finds. When CRISPR was coupled with the enzyme Cas12a, researchers at the University of California, Berkeley, found … |